Genetic Signatures Announces $30 Million Capital Raising
Filed with ASX · · 8 pages · English
3468-3105-0285, v. 2
Genetic Signatures Ltd. on 6ix
In the deck
Story so far
Earlier from Genetic Signatures
- Genetic Signatures Appoints Allison Rossiter As CEO
- FDA Clearance For Gastrointestinal Parasite Detection Kit
- Trading Halt
- Decision to Cease Development of US Respiratory Product
- Leadership Transition at Genetic Signatures
Later from Genetic Signatures
- FDA Clearance and Capital Raising Presentation
- Completion of Institutional Entitlement Offer and Placement
- Despatch Of Retail Entitlement Offer Booklet
- Appendix 4E and Annual Report
- 2024 AGM Chairman's Address and CEO Presentation
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures